-
1.
公开(公告)号:US08962026B2
公开(公告)日:2015-02-24
申请号:US12567571
申请日:2009-09-25
申请人: James R. Baker, Jr. , Mark R. Hemmila , Stewart C. Wang , Tarek Hamouda , John J. LiPuma , Jessica A. Knowlton , Paul E. Makidon , Luz P. Blanco , Jeffery V. Groom, II , Anna U. Bielinska
发明人: James R. Baker, Jr. , Mark R. Hemmila , Stewart C. Wang , Tarek Hamouda , John J. LiPuma , Jessica A. Knowlton , Paul E. Makidon , Luz P. Blanco , Jeffery V. Groom, II , Anna U. Bielinska
IPC分类号: A61K9/107
CPC分类号: A61K31/198 , A61K9/1075 , A61K31/045 , A61K31/047 , A61K31/14 , A61K31/341 , A61K31/4425 , A61K45/06
摘要: The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a Burkholderia antigen) that generate an effective immune response (e.g., against a bacterial species of the genus Burkholderia) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
摘要翻译: 本发明涉及治疗性纳米乳剂组合物及其利用方法。 特别地,本文描述了用于治疗和/或预防感染(例如,呼吸道感染(例如,与囊性纤维化相关)),烧伤伤口管理和免疫原性组合物(例如,包含伯克霍尔德氏菌(Burkholderia))的纳米乳剂组合物 抗原),其在施用免疫原性组合物的受试者中产生有效的免疫应答(例如,针对伯克霍尔德氏菌属的细菌物种)。 本发明的组合物和方法尤其可用于临床(例如治疗和预防性药物),工业和研究应用。
-
公开(公告)号:US20100203139A1
公开(公告)日:2010-08-12
申请号:US12567571
申请日:2009-09-25
申请人: James R. Baker, JR. , Mark R. Hemmila , Stewart C. Wang , Tarek Hamouda , John J. LiPuma , Jessica A. Knowlton , Paul E. Makidon , Luz P. Blanco , Jeffery V. Groom, II , Anna U. Bielinska
发明人: James R. Baker, JR. , Mark R. Hemmila , Stewart C. Wang , Tarek Hamouda , John J. LiPuma , Jessica A. Knowlton , Paul E. Makidon , Luz P. Blanco , Jeffery V. Groom, II , Anna U. Bielinska
CPC分类号: A61K31/198 , A61K9/1075 , A61K31/045 , A61K31/047 , A61K31/14 , A61K31/341 , A61K31/4425 , A61K45/06
摘要: The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a Burkholderia antigen) that generate an effective immune response (e.g., against a bacterial species of the genus Burkholderia) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
-